ALLOGENE THERAPEUTICS INC (ALLO) Institutional Ownership and Insiders Activity
ALLOGENE THERAPEUTICS INC (ALLO) is widely held by institutional investors, with 203 firms reporting positions valued at approximately $651.40M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $62.71M in ALLO holdings in its latest filing.
Recent insider activity includes 1 tracked Form 4 transaction over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
203
Total Reported Value
$651.40M
Largest Holder
Blackrock, Inc.
Largest Position
$62.71M
Insider Transactions (90d)
1
Latest Filing Quarter
Q2 2026
New Institutional Positions
36
Funds Exiting Positions
37
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$62.71M
- Pfizer Inc$46.93M
- Frazier Life Sciences Management, L.P.$46.69M
- State Street Corp$39.57M
- Tpg Gp A, Llc$38.93M
ALLO News
All news- Pfizer Inc Portfolio Analysis: Q2 2026 Investment Activity
Aug 17, 2026 · valut.ai
- Wildcat Capital Management Q2 2026 Portfolio Activity: Significant Increase in Chime Finl Inc (CHYM)
Jul 25, 2026 · valut.ai
Related ALLO Institutional Insights:
- ALLO 13F Institutional Holders
- ALLO Top Institutional Shareholders
- ALLO Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ALLO Insider Trading & SEC Form 4 Activity
- ALLO Articles
- Top Institutional Investor Stock Rankings